284 related articles for article (PubMed ID: 14678651)
1. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
Başalp A; Yücel F
Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
[TBL] [Abstract][Full Text] [Related]
2. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
3. Establishment of human Ig producing heterohybridomas by fusion of mouse myeloma cells with human lymphocytes derived from peripheral blood, bone marrow, spleen, lymph node, and synovial fluid. Effect of polyclonal prestimulation and cryopreservation.
Jahn S; Grunow R; Kiessig ST; Specht U; Matthes H; Hiepe F; Hlinak A; Von Baehr R
J Immunol Methods; 1988 Feb; 107(1):59-66. PubMed ID: 3343518
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of spleen and lymph nodes as a source of mononuclear cells to be used for the development of monoclonal antibody producing hybridoma cells.
Sogut I; Hatipoglu I; Serhatli M; Cevik SI; Durali D; Basalp A
Cryo Letters; 2011; 32(3):266-74. PubMed ID: 21766156
[TBL] [Abstract][Full Text] [Related]
5. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
[TBL] [Abstract][Full Text] [Related]
6. Improved fusion technique. II. Stability and purity of hybrid clones.
Westerwoudt RJ; Naipal AM; Harrisson CM
J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
[TBL] [Abstract][Full Text] [Related]
7. Production of a highly specific monoclonal antibody progesterone.
White A; Anderson DC; Daly JR
J Clin Endocrinol Metab; 1982 Jan; 54(1):205-7. PubMed ID: 7054217
[TBL] [Abstract][Full Text] [Related]
8. A comparison of spleen and lymph node cells as fusion partners for the raising of monoclonal antibodies after different routes of immunisation.
Mirza IH; Wilkin TJ; Cantarini M; Moore K
J Immunol Methods; 1987 Dec; 105(2):235-43. PubMed ID: 3320207
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
North SM; Styles JM; Hobbs SM; Dean CJ
Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM
Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
[TBL] [Abstract][Full Text] [Related]
11. Strategies in the development of human monoclonal antibodies.
Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
[TBL] [Abstract][Full Text] [Related]
12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
13. Specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma.
Tucker EM; Dain AR; Clarke SW; Donker RA
Hybridoma; 1984; 3(2):171-6. PubMed ID: 6480023
[TBL] [Abstract][Full Text] [Related]
14. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
[TBL] [Abstract][Full Text] [Related]
15. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
Orlik O; Altaner C
J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
[TBL] [Abstract][Full Text] [Related]
16. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
Miyahara M; Nakamura H; Hamaguchi Y
Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
[TBL] [Abstract][Full Text] [Related]
17. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
[TBL] [Abstract][Full Text] [Related]
18. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal Antibodies Against Porcine sIgA and Their Use in Immunohistochemistry.
Song W; Feng Z; Bai Y; Wang H; Ishag HZ; Yang R; Hua L; Chen C; Zhang Z; Shu C; Liu M; Xiong Q; Shao G
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):386-9. PubMed ID: 26683177
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous fusion between splenocytes and myeloma cells induced by bacterial immunization.
Verschoor JA; Boshoff CH; Coetzee L; Van Wyngaardt S; Visser L
Hybridoma; 1990 Oct; 9(5):511-8. PubMed ID: 2258187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
